Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group - Test2 - elhamkhani - TriplyDB

Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group

Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group

http://www.wikidata.org/entity/Q28260147

about

sameAs

Selenium supplementation for critically ill adults Selenium supplementation for critically ill adults Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila A safe lithium mimetic for bipolar disorder Neuroprotection for ischemic stroke: past, present and future Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neurons Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?Strategies for Pharmacological Organoprotection during Extracorporeal Circulation Targeting Ischemia-Reperfusion Injury Oxidative Stress and the Use of Antioxidants in Stroke NADPH oxidase in stroke and cerebrovascular disease Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement Antioxidants: The new frontier for translational research in cerebroprotection Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2 Pharmacology of iron transport Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi Inactivation of the Mycobacterium tuberculosis Antigen 85 Complex by Covalent, Allosteric Inhibitors Advances in the Microbiome: Applications to Clostridium difficile Infection Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling A target-based high throughput screen yields Trypanosoma brucei hexokinase small molecule inhibitors with antiparasitic activity Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans.Intranasal pyrrolidine dithiocarbamate decreases brain inflammatory mediators and provides neuroprotection after brain hypoxia-ischemia in neonatal rats.Identification of small molecules that inhibit the interaction of TEM8 with anthrax protective antigen using a FRET assay.What animal models have taught us about the treatment of acute stroke and brain protection.Selenium-containing 15-mer peptides with high glutathione peroxidase-like activity.Advances in ischemic stroke treatment: neuroprotective and combination therapies.Absence of glutathione peroxidase-1 exacerbates cerebral ischemia-reperfusion injury by reducing post-ischemic microvascular perfusion.Protection against peroxynitrite.Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action.New insights on NOX enzymes in the central nervous system.Neuroprotection in acute ischaemic stroke. II: Clinical potential.Molecular Dissection of Cyclosporin A's Neuroprotective Effect Reveals Potential Therapeutics for Ischemic Brain Injury.Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse Selenite stimulates mitochondrial biogenesis signaling and enhances mitochondrial functional performance in murine hippocampal neuronal cells XAS studies of Se speciation in selenite-fed rats.Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.Selenium-based pharmacological agents: an update.Neuroprotective agents for the treatment of acute ischemic stroke.

P2860

Q24186311-4460A2F8-58D2-48CD-9F66-68AA9EEDDBB0 Q24246013-397CE673-E3C0-4352-9650-9CA5AF8DFC5A Q24322678-29C542C5-773A-46F4-821B-2A111C245CAC Q24322678-A4465C29-A16B-4B3F-9D6F-C8A7E249C061 Q24600175-6DCE55C3-20F7-4A04-B91E-621E80D9285B Q24600175-D3B3C86D-A331-4D35-87C5-C10C8BC56053 Q24645185-9DAFF9B4-599B-44F4-BB9C-B748360785DB Q24645185-D224115C-D67A-4F5E-A755-2824615F3C09 Q24657218-049EC090-1EFA-4395-BEBD-E96DDFA10C26 Q24657218-ED413F81-0FA7-4A7F-B2E9-383B4B689969 Q26741451-9CDEB373-C050-433F-8DFF-E2A6C8729E72 Q26741451-CAE7330C-022A-4039-B748-A6254D721426 Q26751153-07428ED8-B99F-4C38-9D14-0A0EAE8EB8ED Q26751153-5B140494-F16F-4664-BC16-DBC76AD9400B Q26770727-8FDEE446-08EE-4888-94C5-29D3E47C611A Q26770727-E5253185-E4CE-4E41-98F5-0DBC355D7ACA Q26852796-06831309-6235-4548-A6C6-A873C659D3C0 Q26852796-3901637B-DDB2-487C-ADDA-4A9B8745BA6F Q26859140-5D015127-BA5A-4AB8-B3A9-B0F5E87E9B77 Q26859140-9A4D698C-5A77-4270-B070-599264400D32 Q26861119-8876A4C0-4D5E-4069-806D-EB6A2DBE5393 Q26861119-E3775E4E-9155-4FCB-B229-EA13F9767F8D Q26863595-9F40DFCB-B0EF-44C5-9536-B637C2DD77E0 Q26863595-AFA57CDE-C518-4677-B014-0799497AF3A7 Q27005956-2AB99CAE-60D6-4D5E-9C52-A0AA3DDEED10 Q27005956-2DEB8180-2678-44C4-93AD-8EC7C395C1E7 Q27009387-4878150A-EE37-4413-83A5-8E8ECE2FD6D2 Q27009387-7B0D26A3-9467-4113-80B5-5B3BB7CE2F32 Q27657406-073B755F-DA2D-400D-9D42-36321740C4C8 Q27657406-7B1C1395-FBBD-461F-A790-E17AF67798DC Q27684704-291457E3-486C-427B-875E-DF6185124DF0 Q27684704-8D9A4A11-041C-4AF3-A7E0-FF8DA33F4C40 Q28066362-25DFAC01-5F5D-4C34-9889-EBD0D11B28EB Q28066362-9CA5F6A7-7E00-4353-A3BB-1DF58A38D8AA Q28389739-65055C68-D575-4063-B11A-089696083F09 Q28389739-CA6203D5-1ADF-4733-9F2B-B3D11E5F9F97 Q28473648-63BFB931-CBF8-4063-B38D-E0A7E9318C6C Q28473648-BAB41D1D-0EF5-4FDB-B62E-B61B5D66C1CE Q30374052-61D19D24-8E28-4489-B99E-1172F0F28B0F Q30409756-BFC60A81-DC61-49C4-8616-81DA12F54233

P2860

Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group

http://www.wikidata.org/entity/Q28260147

description

1998 nî lūn-bûn

@nan

1998 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group

@ast

Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group

@en

Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group

@nl

type

label

Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group

@ast

Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group

@en

Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group

@nl

altLabel

Ebselen in Acute Ischemic Stroke : A Placebo-Controlled, Double-blind Clinical Trial

@ast

Ebselen in Acute Ischemic Stroke : A Placebo-Controlled, Double-blind Clinical Trial

@en

prefLabel

Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group

@ast

Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group

@en

Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group

@nl

P1433

Q28260147-65745BA1-6C2B-4037-A449-432CB97CFDE0

P1476

Q28260147-3625105D-8337-4B85-A6D2-BF90EA120E45

Q28260147-EE609F29-F65F-4BF2-98E6-2E96442B505B

P2093

Q28260147-08E56F07-BFC2-432C-991B-0210493519AA

Q28260147-355671F7-A04A-4CFD-959C-0A2706101A12

Q28260147-4A31BB4D-7CA1-46EF-87D9-C85725B5A61D

Q28260147-4ED71643-1633-41C1-B52E-C685471ADCA2

Q28260147-502B3649-085C-4125-96B6-09F9A53CD827

Q28260147-5BBABA0F-0051-4CDE-8A3C-DE1B5B81FE6E

Q28260147-5BD3688D-6EC5-4A68-8F2E-59328C1B00AE

Q28260147-63D41F82-7D88-46BF-937B-AB4E9F71A932

Q28260147-89E179F3-1CDD-491D-9485-E4B40219D5E2

Q28260147-8C79722D-4691-451C-82A9-B44A42709E99

P304

Q28260147-57159E14-2052-4B6F-8BCD-1C6EBF02A66C

Q28260147-BE03370C-771F-4F87-940A-202BABA9C58C

P31

Q28260147-D14052A2-22D6-4033-A7A3-1899869C48DA

P3181

Q28260147-38DF531A-EF84-4BCB-9DED-F4804DE351E2

P356

Q28260147-D953B6B9-96C8-44EC-B8C4-4717CBADC8EC

P407

Q28260147-B0DC518B-32E5-4128-85DE-8FFDFA369966

P433

Q28260147-10182C5B-BFB6-470C-937E-9C896E9F128A

P478

Q28260147-995009A5-AB14-4CCD-8CD1-9F7653398CD7

P577

Q28260147-3797E529-D779-4E2C-8571-720CF6AEF39B

Q28260147-D8FF89E1-6525-45CC-A843-F866C9887411

P698

Q28260147-D424262A-89D7-4425-A5C8-08C0825D1845

P921

Q28260147-23B66146-9984-4FCB-8AA8-BB4C46777EA9

Q28260147-9ACE0188-6F13-4FFF-B8EA-FDF9D7003BBB

P3181

P356

P1433

P1476

Ebselen in Acute Ischemic Stroke : A Placebo-Controlled, Double-blind Clinical Trial

@en

Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group

@en

P2093

H Yasuhara

http://www.w3.org/2001/XMLSchema#string

H. Yasuhara

http://www.w3.org/2001/XMLSchema#string

I Saito

http://www.w3.org/2001/XMLSchema#string

I. Saito

http://www.w3.org/2001/XMLSchema#string

K Sano

http://www.w3.org/2001/XMLSchema#string

K Takakura

http://www.w3.org/2001/XMLSchema#string

K. Sano

http://www.w3.org/2001/XMLSchema#string

K. Takakura

http://www.w3.org/2001/XMLSchema#string

T Asano

http://www.w3.org/2001/XMLSchema#string

T Yamaguchi

http://www.w3.org/2001/XMLSchema#string

P304

12-17

http://www.w3.org/2001/XMLSchema#string

12-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2762778

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/01.STR.29.1.12

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

1998-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9445321

http://www.w3.org/2001/XMLSchema#string

P921